Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer

Xilio Therapeutics Inc. (Nasdaq: XLO) has appointed biopharmaceutical legal executive Ben Harshbarger as chief legal officer, adding experienced leadership as... Read More

The post Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer appeared first on citybiz.